Diagnostics
Freenome, headquartered in South San Francisco, is focused on developing a diagnostic test for early detection of cancer and other diseases on the so-called “liquid biopsy,” in other words, blood.
A new application for its Apple Watch could save thousands of lives.
LifeOmic is planning to build new headquarters at the Indiana University Emerging Technology Center.
The addition of Pellini means the San Diego-based firm launched earlier this year can increase its investing pace and tap his healthcare experience as an executive at Foundation.
Apostle, headquartered in Sunnyvale, Calif., hopes to file an IPO or establish other strong business collaborative routes in five years.
BioSpace is proud to present its NextGen “Class of 2018,” a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
There’s been a major shakeup in the executive team at Human Longevity.
HeartFlow makes software that builds a 3D model of your heart’s arteries, based on CT scans.
Foundation Medicine’s sequencing diagnostics test for solid tumors that can detect cancer-causing mutations in 324 genes was approved by the FDA Thursday.
Mettler-Toledo will begin to issue pink slips in March to employees at an upstate New York manufacturing facility.
PRESS RELEASES